| Authors: |
Van-Tilbeurgh M; Université Paris-Saclay, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184), Fontenay-aux-Roses & Le Kremlin- Bicêtre, Inserm, France., Yang W; Metabolomics and Analytics Centre, Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, the Netherlands.; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands., Lopez EM; Université Paris-Saclay, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184), Fontenay-aux-Roses & Le Kremlin- Bicêtre, Inserm, France., Gallouët AS; Université Paris-Saclay, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184), Fontenay-aux-Roses & Le Kremlin- Bicêtre, Inserm, France., Dagg B; Vaccines Division, Medicines and Healthcare products Regulatory Agency, South Mimms, EN6 3QG, Hertfordshire, United Kingdom., Goulding S; Vaccines Division, Medicines and Healthcare products Regulatory Agency, South Mimms, EN6 3QG, Hertfordshire, United Kingdom., Keeble J; Vaccines Division, Medicines and Healthcare products Regulatory Agency, South Mimms, EN6 3QG, Hertfordshire, United Kingdom., Ho MM; Vaccines Division, Medicines and Healthcare products Regulatory Agency, South Mimms, EN6 3QG, Hertfordshire, United Kingdom., Harms A; Metabolomics and Analytics Centre, Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, the Netherlands., Grand RL; Université Paris-Saclay, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184), Fontenay-aux-Roses & Le Kremlin- Bicêtre, Inserm, France., Khatri B; Vaccines Division, Medicines and Healthcare products Regulatory Agency, South Mimms, EN6 3QG, Hertfordshire, United Kingdom. Bhagwati.khatri@mhra.gov.uk. |